Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

William Demant Holding A/S: Financial calendar 2017

William Demant Holding A/S
Posted on: 21 Sep 16

Company announcement no 2016-12                            21 September 2016
Financial calendar 2017

The Board of Directors of William Demant Holding A/S has set the following dates for publication of the Company's Annual Report, Interim Report and Interim Management Statements as well as holding of the annual general meeting in 2017:

13 February 2017 Deadline for submission of items for the agenda of the annual general meeting *
2 to 22 February 2017Quiet period prior to publication of Annual Report 2016
23 February 2017Annual Report 2016
27 March 2017Annual general meeting
18 April to 8 May 2017Quiet period prior to publication of Interim Management Statement
9 May 2017Interim Management Statement
24 July to 13 August 2017Quiet period prior to publication of Interim Report 2017
14 August 2017Interim Report 2017
19 October to 8 November 2017Quiet period prior to publication of Interim Management Statement
9 November 2017Interim Management Statement

* Please note that if a shareholder would like to have a specific item included in the agenda for the general meeting on 27 March 2017, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than Monday 13 February 2017.


Further information:                                                          
Søren B. Andersson, VP Investor Relations
Phone +45 39 17 73 00

2016-12 Financial calendar 2017

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: William Demant Holding A/S via GlobeNewswire

Last updated on: 22/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.